DI
BMY icon

DAGCO Inc’s Bristol-Myers Squibb BMY Stock Holding History

DAGCO Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,550
Closed -$193K – 221
2024
Q1 		$193K Buy
3,550
+2,960
+502% +$151K 0.09% 77
2023
Q4 		$30.3K Sell
590
-12,873
-96% -$676K 0.03% 133
2023
Q3 		$4.5M Buy
13,463
+8,472
+170% +$519K 2.32% 11
2023
Q2 		$319K Sell
4,991
-545
-10% -$36.5K 0.16% 71
2023
Q1 		$384K Buy
5,536
+6
+0.1% +$423 0.21% 69
2022
Q4 		$398K Sell
5,530
-145
-3% -$10.9K 0.23% 70
2022
Q3 		$403K Sell
5,675
-346
-6% -$25.1K 0.25% 69
2022
Q2 		$464K Buy
6,021
+5
+0.1% +$381 0.24% 75
2022
Q1 		$460K Sell
6,016
-144
-2% -$9.67K 0.21% 79
2021
Q4 		$384K Sell
6,160
-445
-7% -$26.1K 0.15% 93
2021
Q3 		$391K Sell
6,605
-144
-2% -$9.48K 0.17% 88
2021
Q2 		$451K Sell
6,749
-419
-6% -$27.3K 0.2% 83
2021
Q1 		$453K Sell
7,168
-294
-4% -$18.3K 0.23% 83
2020
Q4 		$463K Sell
7,462
-219
-3% -$13.5K 0.26% 78
2020
Q3 		$463K Sell
7,681
-94
-1% -$5.66K 0.31% 76
2020
Q2 		$457K Sell
7,775
-144
-2% -$8.61K 0.46% 62
2020
Q1 		$441K Sell
7,919
-120
-1% -$7.33K 0.48% 63
2019
Q4 		$516K Sell
8,039
-194
-2% -$11.1K 0.46% 71
2019
Q3 		$418K Sell
8,233
-319
-4% -$15K 0.42% 72
2019
Q2 		$388K Sell
8,552
-143
-2% -$6.66K 0.41% 73
2019
Q1 		$415K Sell
8,695
-594
-6% -$29.6K 0.45% 72
2018
Q4 		$483K Buy
+9,289
New +$499K 0.6% 65

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DAGCO Inc's BMY Position: Q2 2024 in Review

DAGCO Inc sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 3,550 shares — an estimated $193K sold.

DAGCO Inc first reported a position in BMY in Q4 2018 and held it in 22 quarters. The position peaked at $4.5M in Q3 2023. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • DAGCO Inc reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • DAGCO Inc sold 3,550 Bristol-Myers Squibb shares in Q2 2024, an estimated $193K.
  • DAGCO Inc first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 22 quarters.
  • DAGCO Inc's Bristol-Myers Squibb position peaked at $4.5M in Q3 2023.
  • 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on DAGCO Inc's 13F filing for Q2 2024, filed 14 Aug 2024.